tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market

Cartesian Therapeutics (RNAC) Cash flow

Compare
1,149 Followers

Cartesian Therapeutics Cash Flow

RNAC's free cash flow for Q4 2025 was $-18.20M. For the 2025 fiscal year, RNAC's free cash flow was decreased by $-46.63M and operating cash flow was $-17.71M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -73.94M$ -23.67M$ -51.16M$ -31.63M$ -60.38M
Investing Cash Flow
$ -5.45M$ -8.74M$ 34.61M$ -15.00M$ -17.14M
Financing Cash Flow
$ -8.05M$ 168.43M$ -13.14M$ 39.22M$ 52.90M
End Cash Position
$ 126.87M$ 214.28M$ 78.29M$ 108.04M$ 115.44M
Free Cash Flow
$ -79.39M$ -32.77M$ -51.37M$ -32.83M$ -61.47M
Currency in USD

Cartesian Therapeutics Cash Flow